129
Views
42
CrossRef citations to date
0
Altmetric
Original Articles

Hepatic encephalopathy

Metabolic consequence of cirrhosis often is reversible

, MD & , MD
Pages 52-70 | Published online: 06 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Guy W Neff, Nyingi Kemmer, Christopher Duncan & Angel Alsina. (2013) Update on the management of cirrhosis – focus on cost-effective preventative strategies. ClinicoEconomics and Outcomes Research 5, pages 143-152.
Read now
Amal M. El-Shehaby, Eman M. Obaia, Sahar S. Alwakil & Ahmed A. Hiekal. (2010) Total and acylated ghrelin in liver cirrhosis: Correlation with clinical and nutritional status. Scandinavian Journal of Clinical and Laboratory Investigation 70:4, pages 252-258.
Read now

Articles from other publishers (40)

Daniele Bellafante, Stefania Gioia, Jessica Faccioli, Oliviero Riggio, Lorenzo Ridola & Silvia Nardelli. (2023) Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution. Journal of Clinical Medicine 12:3, pages 1187.
Crossref
Shivani Apurva Patel, Seema Sharma, Asif Rahman, Vaibhav Daftary & Prarthi Shah. (2018) PHES: RELIABLE, BED SIDE DIAGNOSTIC TOOL IN IDENTIFICATION OF MINIMAL HEPATIC ENCEPHALOPATHY. Journal of Evidence Based Medicine and Healthcare 5:35, pages 2529-2535.
Crossref
Benhar NVA & Vijaya Kumar H. (2017) EPIDEMIOLOGY AND CLINICAL PROFILE OF HEPATIC ENCEPHALOPATHY IN TERTIARY CARE HOSPITAL, GGH, KAKINADA. Journal of Evidence Based Medicine and Healthcare 4:24, pages 1379-1388.
Crossref
Tribeni Sharma, Debabrata Goswami, Abdul Barik Ahmed, Bhaskar Brahma & Phirney Jessica Ingtipi. (2016) A CLINICAL STUDY OF HEPATIC ENCEPHALOPATHY IN CHRONIC LIVER DISEASE WITH REFERENCE TO SERUM AMMONIA IN A TERTIARY CARE HOSPITAL OF NORTH EAST INDIA. Journal of Evidence Based Medicine and Healthcare 3:59, pages 3178-3184.
Crossref
DaiWai M. Olson, Hunt H. Batjer, Kamal Abdulkadir & Christiana E. Hall. (2013) Measuring and Monitoring ICP in Neurocritical Care: Results from a National Practice Survey. Neurocritical Care 20:1, pages 15-20.
Crossref
Khaled Amer, Mohamed S. Hashim, Eman Abd El Sameea, Manar Obada, Mostafa G. El Helbawy, Ahmed Edrees, Tary A. Salman, Omkolsoum Al Haddad & Mohsen Salama. (2013) Evaluation of rifaximin in Egyptian patients with hepatic encephalopathy. Egyptian Liver Journal 3:4, pages 113-117.
Crossref
Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu & Chuan-Yong Guo. (2013) Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis. Gastroenterology Research and Practice 2013, pages 1-9.
Crossref
Garmen A. Woo & Christopher O'Brien. (2012) Long-term Management of Alcoholic Liver Disease. Clinics in Liver Disease 16:4, pages 763-781.
Crossref
Anna Cave & Adrian Barnardo. (2012) Alcoholic Liver Disease. InnovAiT: Education and inspiration for general practice 5:7, pages 393-399.
Crossref
Anthony Amato, Gavin W Britz, Michael L James, Carmelo Graffagnino, Ali R Zomorodi, Margaret E Zomorodi & DaiWai M Olson. (2011) An observational pilot study of CSF diversion in subarachnoid haemorrhage. Nursing in Critical Care 16:5, pages 252-260.
Crossref
Troy W. PrivetteJr.Jr., Matthew C. Carlisle & James K. Palma. (2011) Emergencies of the Liver, Gallbladder, and Pancreas. Emergency Medicine Clinics of North America 29:2, pages 293-317.
Crossref
Juan Francisco Rivera Ramos & Celina Rodríguez Leal. (2011) Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Annals of Hepatology 10, pages S36-S39.
Crossref
Victor L. ScottIIII, Kerri M. Wahl, Kyle Soltys, Kumar G. Belani, David S. Beebe & Peter J. Davis. 2011. Smith's Anesthesia for Infants and Children. Smith's Anesthesia for Infants and Children 889 949 .
Paula V. Phongsamran, Jiwon W. Kim, Jennifer Cupo Abbott & Angela Rosenblatt. (2010) Pharmacotherapy for Hepatic Encephalopathy. Drugs 70:9, pages 1131-1148.
Crossref
Praveen Sharma, Barjesh Chander Sharma & Shiv Kumar Sarin. (2010) Predictors of nonresponse to lactulose in patients with cirrhosis and hepatic encephalopathy. European Journal of Gastroenterology & Hepatology 22:5, pages 526-531.
Crossref
Lewis W. Teperman & Vincent P. Peyregne. (2010) Considerations on the Impact of Hepatic Encephalopathy Treatments in the Pretransplant Setting. Transplantation 89:7, pages 771-778.
Crossref
C. Spencer Yost & Claus U. Niemann. 2010. Miller's Anesthesia. Miller's Anesthesia 2155 2184 .
Vinay Sundaram & Obaid S. Shaikh. (2009) Hepatic Encephalopathy: Pathophysiology and Emerging Therapies. Medical Clinics of North America 93:4, pages 819-836.
Crossref
Abraham Lemberg & Maria Alejandra Fernández. (2009) Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress. Annals of Hepatology 8:2, pages 95-102.
Crossref
Qian Jiang, Xue-Hua Jiang, Ming-Hua Zheng & Yong-Ping Chen. (2009) l-Ornithine-l-aspartate in the management of hepatic encephalopathy: A meta-analysis. Journal of Gastroenterology and Hepatology 24:1, pages 9-14.
Crossref
Rachel Tavares de Melo, Lisa Charneski & Olga Hilas. (2008) Rifaximin for the treatment of hepatic encephalopathy. American Journal of Health-System Pharmacy 65:9, pages 818-822.
Crossref
Suzanne Sargent. (2007) Pathophysiology and management of hepatic encephalopathy. British Journal of Nursing 16:6, pages 335-339.
Crossref
Carroll B. Leevy & James A. Phillips. (2007) Hospitalizations During the Use of Rifaximin Versus Lactulose for the Treatment of Hepatic Encephalopathy. Digestive Diseases and Sciences 52:3, pages 737-741.
Crossref
N. M. BASS. (2007) Review article: the current pharmacological therapies for hepatic encephalopathy. Alimentary Pharmacology & Therapeutics 25, pages 23-31.
Crossref
R WILLIAMS. (2007) Review article: bacterial flora and pathogenesis in hepatic encephalopathy. Alimentary Pharmacology & Therapeutics 25, pages 17-22.
Crossref
K. D. MULLEN. (2007) Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Alimentary Pharmacology & Therapeutics 25, pages 11-16.
Crossref
David Shaw. 2007. xPharm: The Comprehensive Pharmacology Reference. xPharm: The Comprehensive Pharmacology Reference 1 4 .
Roschelle Heuberger. 2006. Integrating Therapeutic and Complementary Nutrition. Integrating Therapeutic and Complementary Nutrition.
Donald J. Hillebrand, Kevin B. Hill, Ke-Qin Hu, Marge Strutt, Barry Wilson, Alfred Cottrell, Sigmund Teichman, Karen Hay & Brian Bull. (2006) Formal Heparin Anticoagulation Protocol Improves Safety of Charcoal-Based Liver-assist Treatments. ASAIO Journal 52:3, pages 334-342.
Crossref
Camila Scorticati, Juan C. Perazzo, Valeria Rettori, Samuel M. McCann & Andrea De Laurentiis. (2006) Role of Ammonia and Nitric Oxide in the Decrease in Plasma Prolactin Levels in Prehepatic Portal Hypertensive Male Rats. Neuroimmunomodulation 13:3, pages 152-159.
Crossref
Davide Festi, Amanda Vestito, Giuseppe Mazzella, Enrico Roda & Antonio Colecchia. (2006) Management of Hepatic Encephalopathy: Focus on Antibiotic Therapy. Digestion 73:1, pages 94-101.
Crossref
Rajaventhan SriRajaskanthan & Victor Preedy. (2006) Diagnosis and management of alcoholic liver disease, a review. Clinical Effectiveness in Nursing 9, pages e286-e294.
Crossref
Kerri M. Robertson, Avinash C. Shukla, Francis X. McGowanJr.Jr., David S. Beebe, Kumar G. Belani & Victor L. Scott. 2006. Smith's Anesthesia for Infants and Children. Smith's Anesthesia for Infants and Children 895 974 .
Suzanne Sargent. (2005) The aetiology, management and complications of alcoholic hepatitis. British Journal of Nursing 14:10, pages 556-562.
Crossref
Josef Finsterer & Elisabeth Bernauer. (2005) Recovery from Parkinson Syndrome and Prolonged Visually Evoked Potentials in Hepatic Encephalopathy. Metabolic Brain Disease 20:1, pages 55-60.
Crossref
Kevin Hill, Ke-Qin Hu, Alfred Cottrell, Sigmund Teichman & Donald J. Hillebrand. (2003) Charcoal-based hemodiabsorption liver support for episodic type C hepatic encephalopathy. The American Journal of Gastroenterology 98:12, pages 2763-2770.
Crossref
M. Lewis & P.D. Howdle. (2003) The neurology of liver failure. QJM 96:9, pages 623-633.
Crossref
Frank Tacke, Georg Brabant, Elmar Kruck, Rüdiger Horn, Patrick Schöffski, Hartmut Hecker, Michael P Manns & Christian Trautwein. (2003) Ghrelin in chronic liver disease. Journal of Hepatology 38:4, pages 447-454.
Crossref
Qing-Gang Hu. (2003) The influence of Enteral Nutrition in postoperative patients with poor liver function. World Journal of Gastroenterology 9:4, pages 843.
Crossref
J.I. Tembl Ferrairó, M. Boscá Blasco & J.J. Vílchez Padilla. (2003) Encefalopatías metabólicas adquiridas. Medicine - Programa de Formación Médica Continuada Acreditado 8:103, pages 5558-5568.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.